600
Y. Nie et al. · Synthesis and Reactivity of Boron-Functionalized C2B5-closo-Carboranes
CH2). – 11B NMR (CDCl3): δ = 6.7 (d, JB,H = 173 Hz, 2 mmol), Pd(PPh3)4 (40 mg, 0.035 mmol). 2e was ob-
B4,6), 1.9 (d, JB,H = 173 Hz, B5), −18.3 (d, JB,H = 180 Hz, tained as a yellow oil (297 mg, 85%). – 1H{11B} NMR
3
B7), −31.9 (s, B1). – 13C NMR (CDCl3): δ = 13.3 (CH3), (CDCl3): δ = 1.37 (t, 6 H, JH,H = 7.7 Hz, CH3), 1.63 (s,
3
22.4 (CH2), 113.9 (br., Ccage). – EI-MS: m/z (%) = 267 (100) 3 H, Me), 2.70 (q, 2 H, JH,H = 7.7 Hz, CH2), 2.71 (q,
3
[M+], 112 (28) [M+ −I−C2H4].
2 H, JH,H = 7.7 Hz, CH2), 3.7 (br., 1 H, B5-H), 4.2 (br.,
2 H, B4,6-H), −1.5 (br., 1 H, B7-H). – 11B NMR (CDCl3):
δ = 6.3 (d, JB,H = 165 Hz, B4,6), 2.2 (d, JB,H = 170 Hz, B5),
−16.3 (s, B1), −20.3 (d, JB,H = 168 Hz, B7). – 13C NMR
(CDCl3): δ = 4.2 (Me), 13.5 (CH3), 22.3 (CH2), 102.4
(MeC ≡), 114.7 (br., Ccage), signal for B-C≡ n.o.. – EI-MS:
m/z (%) = 179 (100) [M+], 164 (82) [M+ −Me]. – HR-
1-Phenylethynyl-2,3-diethyl-2,3-dicarbaheptaborane(7) (2c)
Similar procedure as described for 2a. 2,3-Et2C2B4H6
(340 mg, 2.6 mmol), n-BuLi (2.5 M in hexane, 2.1 ml,
5.25 mmol), PhC≡CBcat (570 mg, 2.6 mmol). 2c was ob-
tained as an orange red oil (393 mg, 63%). – 1H NMR
1
MS (EI): m/z = 180.1801 [M+]; calcd. for 12C9 H1711B5
3
(CDCl3): δ = 1.48 (t, 6 H, JH,H = 7.6 Hz, CH3), 2.82 (q,
180.1796 (∆m = 0.5 mmu).
3
3
2 H, JH,H = 7.6 Hz, CH2), 2.82 (q, 2 H, JH,H = 7.4 Hz,
CH2), 7.37 (m, 5 H, Ph). – 11B NMR (CDCl3): δ = 6.4
(br., B4,6), 1.8 (br., B5), −16.1 (s, B1), −18.7 (br., B7). –
13C NMR (CDCl3): δ = 13.6 (CH3), 22.5 (CH2), 94.1
(PhC≡), 115.1 (br., Ccage), 122.5, 128.2, 128.7, 132.0 (Ph),
signal for B-C≡ n.o.. – EI-MS: m/z (%) = 241 (100) [M+],
1-tert-Butylethynyl-2,3-diethyl-2,3-dicarbaheptaborane(7)
(2f)
Similar procedure as described for 2d. tBuC≡CH
(175 mg, 2.1 mmol), nBuLi (2.5 M in hexane, 0.9 ml,
22 mmol), ZnCl2 (299 mg, 2.5 mmol), 2b (534 mg, 2 mmol),
Pd(PPh3)4 (75 mg, 0.065 mmol). 2f was obtained as a yel-
low oil (292 mg, 66%). – 1H{11B} NMR (CDCl3): δ = 1.05
226 (34) [M+ −Me]. – HR-MS (EI): m/z = 242.1986 [M+];
12
calcd. for
C
1H1911B5 242.1952 (∆m = 3.4 mmu).
14
3
(s, 9 H, tBu), 1.36 (t, 6 H, JH,H = 7.6 Hz, CH3), 2.71 (q,
1-Trimethylsilylethynyl-2,3-diethyl-2,3-dicarbahepta-
borane(7) (2d)
3
4 H, JH,H = 7.6 Hz, CH2), 3.74 (br., 1 H, B5-H), 4.22
(br., 2 H, B4,6-H), −1.5 (br., 1 H, B7-H). – 11B NMR
The zinc reagent was prepared by treatment of
Me3SiC≡CLi (preformed from Me3SiC≡CH and n-BuLi,
218 mg, 2.1 mmol) with a solution of ZnCl2 (286 mg,
2.1 mmol) in THF (6.5 ml) at −10 ◦C, and stirred at r. t. for
2 h. In another flask, a solution of 2b (534 mg, 2 mmol) in
THF (10 ml) was added to a solution of Pd(PPh3)4 (75 mg,
0.065 mmol) in THF (10 ml). To the resulting red solu-
tion the zinc reagent was added at r. t. The reaction mix-
ture became yellow during 1 h. After completion all volatiles
were removed in vacuo, the brown residue was extracted
with hexane (40 ml) and filtered. The yellow filtrate was
dried to give 2d as an orange red oil (340 mg, 72%). Af-
ter NMR measurement in CDCl3, pieces of red crystals were
formed, which were identified by X-ray analysis to be trans-
(CDCl3): δ = 6.4 (d, JB,H = 159 Hz, B4,6), 1.3 (d, JB,H
=
199 Hz, B5), −15.9 (s, B1), −20.2 (d, JB,H = 169 Hz, B7). –
13C NMR (CDCl3): δ = 13.3 (CH3), 22.3 (CH2), 29.7,
30.6 (tBu), 104.2 (tBuC ≡), 114.6 (br., Ccage), signal for B-
C≡ n. o.. – EI-MS: m/z (%) = 221 (39) [M+], 206 (100)
[M+ −Me]. – HR-MS (EI): m/z = 222.2273 [M+]; calcd.
12
for
C
1H2311B5 222.2265 (∆m = 0.8 mmu).
12
3,4-Bis[2’,3’-diethyl-2’,3’-dicarbaheptaboranyl(7)-1’]-3-
hexene (3)
Similar procedure as described for 2a. 2,3-Et2C2B4H6
(241 mg, 1.84 mmol), n-BuLi (2.5 M in hexane, 1.5 ml,
3.75 mmol), cis-3,4-bis(dichloroboryl)-3-hexene (227 mg,
0.92 mmol). 3 was obtained as a yellow oil (300 mg, 90%). –
1
Pd(PPh3)2I2. – H{11B} NMR (CDCl3): δ = 0.02 (s, 9 H,
3
1H NMR (CDCl3): δ = 0.61 (t, 6 H, JH,H = 7.5 Hz, Et-
3
SiMe3), 1.36 (t, 6 H, JH,H = 7.6 Hz, CH3), 2.71 (q, 4 H,
CH3), 1.23 (t, 6 H, 3JH,H = 7.5 Hz, cage-CH3), 1.47 (q, 4 H,
3JH,H = 7.6 Hz, CH2), 3.7 (br., 1 H, B5-H), 4.2 (br., 2
H, B4,6-H), −1.7 (br., 1 H, B7-H). – 11B NMR (CDCl3):
δ = 6.3 (br., B4,6), 1.5 (br., B5), −17.4 (s, B1), −19.1 (br.,
B7). – 13C NMR (CDCl3): δ = −0.39 (SiMe3), 13.4 (CH3),
22.4 (CH2), 102.4 (Me3SiC ≡), 114.8 (br., Ccage), signal
for B-C≡n.o. – 29Si NMR (CDCl3): δ = −19.4. – EI-MS:
3
3JH,H = 7.5 Hz, Et-CH2), 2.63 (q, 2 H, JH,H = 7.5 Hz,
3
cage-CH2), 2.67 (q, 2 H, JH,H = 7.6 Hz, cage-CH2). –
11B NMR (CDCl3): δ = 6.2 (br., B4,6), 2.9 (br., B5), −4.7
(s, B1), −21.5 (br., Hz, B7). – 13C NMR (CDCl3): δ = 13.9,
14.1 (CH3), 22.9, 26.5 (CH2), 114.6 (br., Ccage), 144 (br.,
C=C). – EI-MS: m/z (%) = 362 (100) [M+], 333 (680)
[M+ −Et]. – HR-MS (EI): m/z = 364.3893 [M+]; calcd. for
m/z (%) = 237 (16) [M+], 222 (100) [M+ −Me]. – HR-MS
(EI): m/z = 238.2050 [M+]; calcd. for
238.2035 (∆m = 1.5 mmu).
C
1H2311B528Si
11
12
12
11
C
1H38
B
364.3904 (∆m = −1.1 mmu).
18
10
Dicobaltatetrahedrane-substituted closo-C2B5 and nido-
C2B4 carboranes 4c, 5c
1-Methylethynyl-2,3-diethyl-2,3-dicarbaheptaborane(7) (2e)
Similar procedure as described for 2d. MeC≡CLi
A solution of 2c (196 mg, 0.81 mmol) in hexane (15 ml)
(115 mg, 2.5 mmol), ZnCl2 (240 mg, 2.5 mmol), 2b (534 mg, was added to a solution of Co2(CO)8 (276 mg, 0.81 mmol)
Unauthenticated
Download Date | 11/17/19 11:07 PM